NO973426L - Aprotinin-varianter med forbedrede egenskaper - Google Patents

Aprotinin-varianter med forbedrede egenskaper

Info

Publication number
NO973426L
NO973426L NO973426A NO973426A NO973426L NO 973426 L NO973426 L NO 973426L NO 973426 A NO973426 A NO 973426A NO 973426 A NO973426 A NO 973426A NO 973426 L NO973426 L NO 973426L
Authority
NO
Norway
Prior art keywords
improved properties
aprotinin variants
aprotinin
variants
properties
Prior art date
Application number
NO973426A
Other languages
English (en)
Norwegian (no)
Other versions
NO973426D0 (no
Inventor
Werner Schroeder
Soeren Bjoern
Kjeld Norris
Viggo Diness
Leif Noerkskov-Lauritsen
Niels Dyhr Christensen
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO973426D0 publication Critical patent/NO973426D0/no
Publication of NO973426L publication Critical patent/NO973426L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114Kunitz type inhibitors
    • C07K14/8117Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114Kunitz type inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO973426A 1996-07-25 1997-07-24 Aprotinin-varianter med forbedrede egenskaper NO973426L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19629982A DE19629982A1 (de) 1996-07-25 1996-07-25 Aprotinin-Varianten mit verbesserten Eigenschaften

Publications (2)

Publication Number Publication Date
NO973426D0 NO973426D0 (no) 1997-07-24
NO973426L true NO973426L (no) 1998-01-26

Family

ID=7800774

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973426A NO973426L (no) 1996-07-25 1997-07-24 Aprotinin-varianter med forbedrede egenskaper

Country Status (37)

Country Link
US (2) US6482798B2 (fr)
EP (1) EP0821007B1 (fr)
JP (1) JPH10101700A (fr)
KR (1) KR980009283A (fr)
CN (1) CN1172116A (fr)
AR (1) AR008783A1 (fr)
AT (1) ATE260975T1 (fr)
AU (2) AU2870197A (fr)
BG (1) BG101787A (fr)
BR (1) BR9704068A (fr)
CA (1) CA2207071A1 (fr)
CO (1) CO4890857A1 (fr)
CZ (1) CZ236797A3 (fr)
DE (2) DE19629982A1 (fr)
DZ (1) DZ2276A1 (fr)
EE (1) EE9700177A (fr)
ES (1) ES2217350T3 (fr)
HN (1) HN1997000094A (fr)
HR (1) HRP970384A2 (fr)
HU (1) HUP9701290A3 (fr)
ID (1) ID17508A (fr)
IL (1) IL121361A0 (fr)
MA (1) MA24279A1 (fr)
NO (1) NO973426L (fr)
NZ (1) NZ328402A (fr)
PE (1) PE92298A1 (fr)
PL (1) PL321341A1 (fr)
RU (1) RU2197983C2 (fr)
SG (1) SG71714A1 (fr)
SK (1) SK101997A3 (fr)
SV (1) SV1997000068A (fr)
TN (1) TNSN97130A1 (fr)
TR (1) TR199700688A2 (fr)
TW (1) TW480271B (fr)
UA (1) UA55380C2 (fr)
YU (1) YU31697A (fr)
ZA (1) ZA976585B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19725014A1 (de) * 1997-06-13 1998-12-17 Bayer Ag Aprotininvarianten mit verbesserten Eigenschaften und Bikunine von Aprotininvarianten
US6974188B2 (en) * 2003-08-13 2005-12-13 Cosco Management, Inc. Chair with pivotable chair back
US20060218667A1 (en) * 2004-10-12 2006-09-28 Vojdani Fakhrieh S Plant-produced recombinant aprotinin and aprotinin variants
WO2006042327A2 (fr) * 2004-10-12 2006-04-20 Large Scale Biology Corporation Aprotinine de recombinaison d'origine vegetale et variants d'aprotinine
PL2360258T3 (pl) * 2005-02-18 2015-03-31 Angiochem Inc Polipeptydy aprotyniny do transportowania związków przez barierę krew-mózg
WO2008077478A1 (fr) * 2006-12-22 2008-07-03 Bayer Schering Pharma Aktiengesellschaft Préparation et utilisation de variants du domaine 2 de kunitz du gène de la bikunine placentaire humaine
WO2008110301A1 (fr) * 2007-03-13 2008-09-18 Bayer Schering Pharma Aktiengesellschaft Variants d'aprotinine à propriétés améliorées
DE102007056231A1 (de) 2007-09-08 2009-03-12 Bayer Healthcare Ag Herstellung und Verwendung von Varianten humander Kunitz-Typ Protease-Inhibitoren (hKTPI)
BRPI1103921A2 (pt) 2011-08-17 2013-08-06 Mahle Metal Leve Sa camisa de cilindro e liga de ferro fundido

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU560584B2 (en) * 1983-07-28 1987-04-09 Bayer Aktiengesellschaft Homologues of aprotinin
US4595974A (en) * 1984-09-10 1986-06-17 Burroughs Corporation Base drive circuit for a switching power transistor
GB2208511A (en) 1987-08-07 1989-04-05 Bayer Ag Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology
DK225488D0 (da) * 1988-04-26 1988-04-26 Novo Industri As Polypeptid
US5591603A (en) 1987-08-28 1997-01-07 Novo Nordisk A/S Process for preparing aprotinin and aprotinin analogs in yeast cells
DK463887D0 (da) 1987-09-07 1987-09-07 Novo Industri As Gaerleader
DK105489D0 (da) 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid
DE3930522A1 (de) * 1989-09-13 1991-03-21 Bayer Ag Rekombinante aprotinin-varianten - gentechnisches verfahren zur mikrobiellen herstellung von homogen prozessierten aprotinin-varianten sowie die therapeutische anwendung derselben
US5231010A (en) 1989-09-13 1993-07-27 Bayer Aktiengesellschaft Recombinant aprotinin variants genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof
IL99585A0 (en) * 1990-10-01 1992-08-18 Novo Nordisk As Aprotinin analogues,their production and pharmaceutical compositions containing them
US5747449A (en) * 1992-07-13 1998-05-05 Corvas International, Inc. Bovine pancreatic trypsin inhibitor derived inhibitors of factor XA
KR100199565B1 (ko) * 1994-08-19 1999-06-15 차동천 승화형 감열전사 기록용 수용지의 중간층 제조방법

Also Published As

Publication number Publication date
TNSN97130A1 (fr) 2005-03-15
EE9700177A (et) 1998-02-16
JPH10101700A (ja) 1998-04-21
CA2207071A1 (fr) 1998-01-25
ATE260975T1 (de) 2004-03-15
CO4890857A1 (es) 2000-02-28
EP0821007A3 (fr) 1998-11-18
DE19629982A1 (de) 1998-01-29
YU31697A (sh) 1999-07-28
IL121361A0 (en) 1998-01-04
HN1997000094A (es) 1997-12-26
CZ236797A3 (cs) 1998-02-18
NZ328402A (en) 1999-03-29
HRP970384A2 (en) 1998-04-30
ID17508A (id) 1998-01-08
TR199700688A2 (xx) 1998-02-21
BR9704068A (pt) 1999-01-05
NO973426D0 (no) 1997-07-24
AU5178701A (en) 2001-09-06
DE59711356D1 (de) 2004-04-08
EP0821007A2 (fr) 1998-01-28
SG71714A1 (en) 2000-04-18
RU2197983C2 (ru) 2003-02-10
AU762041B2 (en) 2003-06-19
MX9705605A (es) 1998-08-30
SV1997000068A (es) 1998-07-09
HUP9701290A3 (en) 2000-08-28
HU9701290D0 (en) 1997-09-29
BG101787A (en) 1998-10-30
HUP9701290A2 (hu) 1999-06-28
SK101997A3 (en) 1998-03-04
PE92298A1 (es) 1999-02-13
ES2217350T3 (es) 2004-11-01
UA55380C2 (uk) 2003-04-15
ZA976585B (en) 1998-02-03
PL321341A1 (en) 1998-02-02
KR980009283A (ko) 1998-04-30
AU2870197A (en) 1998-02-05
TW480271B (en) 2002-03-21
US20030096752A1 (en) 2003-05-22
MA24279A1 (fr) 1998-04-01
EP0821007B1 (fr) 2004-03-03
AR008783A1 (es) 2000-02-23
US20020103334A1 (en) 2002-08-01
DZ2276A1 (fr) 2002-12-18
US6482798B2 (en) 2002-11-19
CN1172116A (zh) 1998-02-04

Similar Documents

Publication Publication Date Title
DE69627716D1 (de) Perfluorelastomer-zusammensetzung mit erhöhter vulkanisationseigenschaften
ATE208395T1 (de) Thiophenopyrimidine
ATE262512T1 (de) Arylalkanoylpyridazine
ID18010A (id) Oligosakarida termodifikasi
ATE208773T1 (de) Chinoxalindione
DK0832553T3 (da) Mejetærsker
KR980000769U (ko) 병상
ATE353652T1 (de) Östroprogestatives antikonzeptionsmittel
FI962420A0 (fi) Foerstaerkare med laogbrus
NO973426L (no) Aprotinin-varianter med forbedrede egenskaper
NO974125D0 (no) N-benzylazoliumderivater
ID17945A (id) Lemari es
DE59707041D1 (de) Vorspinnmaschine
FR2743439B1 (fr) Enseigne
FI965274A0 (fi) Avverkningsfoerfarande med laong raeckvidd foer klentraed
FI963774A0 (fi) Blomkruka med isolerande stomme
FI963688A0 (fi) Doerrslaos med en fallkolv
FI960990A0 (fi) Sjaelvraeddningsredskap med dubbar
FI2366U1 (fi) Urapaanu
FIU960391U0 (fi) Jääkiekko
NO971171D0 (no) Vasookklusive spiraler med variabelt tverrsnitt
ITFI960107A0 (it) Ancora autodisincagliante
ITFI960041V0 (it) Ancora autodisincagliante
UA25772A (uk) Фуhгіцид тривалої дії
UA1450S (uk) Профіль

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application